Francesc Viñals is the group leader of Molecular signaling in cancer"group in Oncobell. The molecular signalling cascades which are produced at the cell level are essential for responding to changes in its environment or to alter its homeostasis, e.g. at the cell proliferation, movement, growth or metabolism levels. Understanding the mechanism of signal transduction enables…
Read More
Ramon Alemany is the leader of the Cancer Virotherapy Group in Oncobell, which explores new anticancer treatments based on oncolytic adenoviruses. The group aims to design and evaluate oncolytic adenoviruses as antitumour agents for various solid tumours. The main lines of research are tumour targets, intratumoural diffusion through stromal barriers and oncolytic immunotherapy. The group…
Read More
Gabriel Capellá is the group leader of Hereditary Cancer Group in Oncobell, a multidisciplinary research group which has been working in a clinical setting for over 20 years (Hereditary Cancer Programme of the Catalan Institute of Oncology) which provides genetic advice on cancer and molecular tests. The group’s research focusses on improving healthcare for patients…
Read More
Ernest Nadal, along with Josep Mª Piulats, is the group leader of Clinical Research in Solid Tumours Group in Oncobell. His team’s aim is to transform ideas and hypotheses generated in the cancer-treatment environment into personalised therapies, clinical trials and translation projects. This leads to an increase in the social and bibliometric impact of the research…
Read More
Josep Maria Piulats is the group leader of the Clinical Research in Solid Tumours group of Oncobell, within Idibell. His group is striving to become the gateway to purely translational/clinical research generated at the ICO and the academic pathway to introducing new treatments. The team’s aim is to transform ideas and hypotheses generated in the…
Read More
Alberto Villanueva is the group leader of Chemoresistance and predective factors to tumor response and stromal microenvirontment group in Oncobell. His research in cancer is based on the Orthoxenografts®, experimental mouse models in which a small piece of human tumour is implanted (implantation from one spices to another, xenograft) in the same organ of origin…
Read More
LECTURE: He is going to talk about Targeting the IRBC in c-Myc driven tumors in the first Oncobell Symposium. BIOGRAPHY: George Thomas is acknowledged as an innovative leader in the field of signal transduction and growth control based on his seminal studies on the discovery and regulation of the 40S ribosomal protein S6 kinase (S6K1), and more…
Read More
Xavier Matias-Guiu, group leader of the Gynecologic Cancer Group within Oncobell, presents the strategic lines, the current projects and the future goals of his research. The Gynaecological Cancer group is a multidisciplinary team made up of gynaecologists, oncologists, pathologists and basic researchers. The group has three leaders: Xavier Matias-Guiu, who also leads the CIBER group…
Read More
Victor Moreno is group leader of the Colorectal Cancer Group at Oncobell, Professor of Preventive Medicine at the University of Barcelona and Director of the Cancer Prevention and Control Program at the Catalan Institute of Oncology. His main research area is cancer prevention, with special interest in colorectal cancer (CRC). He performs studies on genetic and molecular epidemiology aiming to…
Read More
Isabel Fabregat is Senior Investigator, head of the “TGF-β and Cancer” group at IDIBELL and part-time Associate Professor in the University of Barcelona. The current research line of her laboratory focuses on the dissection of the molecular mechanisms induced by Transforming Growth Factor-beta (TGF-β) in liver cells that can explain its different, and sometimes opposite,…
Read More